Crossref
A narrative review of the efficacy and safety of immunotherapy in triple-negative breast cancer: insights from clinical trials and future perspectives
Breast Communications · 2026-03 · 2 · 3-3
DOI: 10.21037/bc-25-35 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Communications, 2026-03. Verfasst von Bunyese Jenifa Jacob und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jacob, B. J., Shao, X., & Wang, X. (2026). A narrative review of the efficacy and safety of immunotherapy in triple-negative breast cancer: insights from clinical trials and future perspectives. Breast Communications, 2, 3-3. https://doi.org/10.21037/bc-25-35
Vancouver
Jacob BJ, Shao X, Wang X. A narrative review of the efficacy and safety of immunotherapy in triple-negative breast cancer: insights from clinical trials and future perspectives. Breast Communications. 2026;2:3-3. doi:10.21037/bc-25-35
BibTeX
@article{Jacob2026,
author = {Jacob, Bunyese Jenifa and Shao, Xiying and Wang, Xiaojia},
title = {A narrative review of the efficacy and safety of immunotherapy in triple-negative breast cancer: insights from clinical trials and future perspectives},
journal = {Breast Communications},
year = {2026},
volume = {2},
pages = {3--3},
doi = {10.21037/bc-25-35}
}
EUVIMED